Broach Lifecare Hospital Ltd has accepted the resignation of Ms. Urvi Mrunal Hindia from the position of Chief Financial Officer. Her tenure ends at the closure of business hours on August 31, 2026.

The company acknowledged the resignation letter dated August 24, 2026, on August 25, 2026. Ms. Hindia cited personal reasons for her departure from the role.

Regulatory Disclosure

The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026.

Jaykumar Narendra Vyas, Managing Director of the company, signed the communication to the BSE Limited.

Broach Lifecare Hospital Limited has announced its audited standalone financial results for the year and half-year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 21, 2026. The company reported a net profit of ₹8.68 lakh for the full year, a significant decrease from ₹53.59 lakh in the previous year. For the half-year ended March 31, 2026, the company recorded a net loss of ₹22.53 lakh.

Financial Performance

Revenue from operations for the year ended March 31, 2026, rose to ₹599.47 lakh compared to ₹317.94 lakh in the prior year. Total income for the year stood at ₹603.67 lakh. The company's total expenditure increased to ₹582.62 lakh from ₹250.91 lakh in the previous year, primarily driven by higher costs related to purchases of stock-in-trade and employee benefit expenses.

Operational Highlights

The board noted that there were no deviations in the utilization of proceeds from the company's initial public offering (IPO) during the period from October 1, 2025, to March 31, 2026. The IPO funds were raised on August 19, 2024, totaling ₹402 lakh. The trading window for designated persons, which closed on April 1, 2026, will reopen 48 hours after the declaration of these financial results.

The statutory auditors, M/s. K. K. Haryani & Co, issued an audit report with an unmodified opinion on the standalone financial results. Dr. Jaykumar Narendra Vyas, Managing Director, signed the financial results and compliance certificates on behalf of the company.